The Wall Street Journal: FTC won’t block Amazon from buying One Medical parent 1Life


WASHINGTON — Inc. AMZN, -2.70%   will be able to close its purchase of 1Life Healthcare Inc. ONEM, +2.87%,  the operator of the One Medical line of primary-care clinics, without a legal challenge by antitrust enforcers.

The Federal Trade Commission won’t sue in time to block the $3.9 billion deal, including debt, but will continue its investigation of the merger, an agency spokesman said. The decision clears a path for Amazon to substantially expand its healthcare offerings and operate physical medical clinics. Amazon has invested in the healthcare space for years, including with an online pharmacy and other health ventures.

This article was originally published by Read the original article here.

Previous article: Cummins sees its Atmus Filtration business file for an IPO
Next article: Citigroup trims cash incentive, boosts stock portion for CEO Jane Fraser


Please enter your comment!
Please enter your name here